Development
Healwell AI Inc.
AIDX.TO
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 17.00M | 17.32M | 18.04M | 18.22M | 19.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.00M | 17.32M | 18.04M | 18.22M | 19.11M |
| Cost of Revenue | 11.73M | 11.77M | 12.15M | 12.27M | 12.75M |
| Gross Profit | 5.28M | 5.54M | 5.89M | 5.94M | 6.36M |
| SG&A Expenses | 15.53M | 14.63M | 14.07M | 14.61M | 17.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.49M | 31.37M | 32.38M | 33.12M | 34.48M |
| Operating Income | -14.49M | -14.05M | -14.35M | -14.90M | -15.37M |
| Income Before Tax | -22.90M | -21.17M | -15.64M | -13.89M | -14.89M |
| Income Tax Expenses | -1.03M | 1.83M | 1.40M | 906.10K | 1.20M |
| Earnings from Continuing Operations | -21.87 | -23.00 | -17.04 | -14.80 | -16.09 |
| Earnings from Discontinued Operations | 764.60K | 691.70K | -1.26M | -1.32M | -1.32M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -106.40K | -21.50K | 8.40K | -85.30K | -112.20K |
| Net Income | -21.22M | -22.33M | -18.29M | -16.20M | -17.52M |
| EBIT | -14.49M | -14.05M | -14.35M | -14.90M | -15.37M |
| EBITDA | -13.59M | -12.70M | -13.16M | -12.99M | -13.41M |
| EPS Basic | -0.40 | -0.43 | -0.36 | -0.32 | -0.35 |
| Normalized Basic EPS | -0.19 | -0.18 | -0.19 | -0.20 | -0.20 |
| EPS Diluted | -0.40 | -0.43 | -0.36 | -0.32 | -0.35 |
| Normalized Diluted EPS | -0.19 | -0.18 | -0.19 | -0.20 | -0.20 |
| Average Basic Shares Outstanding | 209.75M | 205.95M | 202.16M | 200.30M | 199.86M |
| Average Diluted Shares Outstanding | 209.75M | 205.95M | 202.16M | 200.30M | 199.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.40% | -0.38% | -0.47% | -0.53% | -- |